JONATHAN PATTERSON: Open Payments
NPI 1316646557 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$364 in 19 payments from 11 companies in 2025. Trend: 2023 $75 · 2024 $665 · 2025 $364
Food & beverage: $364
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 4 | $91 |
| Lilly USA, LLC | 5 | $82 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| ANI Pharmaceuticals, Inc. | 1 | $23 |
| Corcept Therapeutics | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $18 |
| Viatris Specialty LLC | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: MOUNJARO, FARXIGA, JARDIANCE, REXULTI, PURIFIED CORTROPHIN GEL, ZEPBOUND, Korlym, Wegovy.
Industry payments across SC — which companies pay providers there.
